Clinical Trials Insight: 700028965
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2007
At a glance
- Drugs Influenza A vaccine H5N1-Baxter (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Baxter International; DynPort Vaccine Company
- 30 Nov 2007 New trial record.
- 27 Nov 2007 Patient enrolment is expected to begin in 2008.